Company expects to begin building four more domestic manufacturing sites this year and add 13,000 high-wage manufacturing and construction jobs in America
Consolidated manufacturing volumes for Q3 FY25 remained stable at 132,187 KL, while for 9M FY25 it stood at 372,505 KL
_256_384.jpg)
Mesalazine is used to treat inflammatory bowel disease
Dr. Smith brings 30 years of clinical and translational research experience in obesity, diabetes, and metabolism with over 300 scientific publications
Increases speed to market for drug developers working on nucleic acid therapeutics
These initiatives will strengthen the company’s capital base, providing financial flexibility for future
The huminsulin range of products is indicated for the treatment of type 1 and type 2 diabetes mellitus to improve blood sugar control in both adults and childre
Parents, teachers, and caregivers play a vital role in spotting early signs of schizophrenia
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
